Aeglea Biotherapeutics shares owned by Emerald Advisers
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Emerald Advisers
from 13F filings
Historical chart of Emerald Advisers investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aeglea Biotherapeutics by Emerald Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $8.6M | 293k | 29.41 |